A Comparison of the Performance of Standard Double Lumen Tubes With Vivasight DL™ Double Lumen Tubes for Lung Isolation in Patients Undergoing Thoracic Surgery

March 15, 2013 updated by: John Laffey
The investigators have performed a number of studies on novel airway devices. In this randomized controlled trial he investigators would like to compare the performance of a new double-lumen endotracheal tube incorporating internal camera (Vivasight DL) with a standard double lumen tube.

Study Overview

Detailed Description

Single lung ventilation is frequently carried out to facilitate surgery on the lungs and pleura. In most instances this is achieved by insertion of a double-lumen endotracheal tube and then selectively ventilating one lung or both. Precise positioning of these tubes is essential for optimal performance. It has become the standard of care to perform bronchoscopy to confirm tube position.

A new double lumen endotracheal tube (Vivasight DL) has recently been developed. It has all the features of a standard double lumen endotracheal tube but also incorporates an internal camera which, when connected to an external screen, allows continuous confirmation of tube position.

This is randomized, single blinded controlled trial. The participants will be allocated to two study groups (Vivasight DL or standard DLT), in which the primary airway management device will be respectively Vivasight DL double lumen tube or a standard double lumen endotracheal tube.

Clinical Research Ethics Committee approval has been obtained. Suitable participants will be recruited after written informed consent.

Standard anesthetic preassessment and anesthesia will be provided.

Consenting patients passing the inclusion and exclusion criteria will be randomly allocated to either of the 2 study groups.

Protocol for attempts at placement and tube position confirmation will be followed.

The investigators will monitor a number of parameters, including time and ease of tube insertion, ability to verify tube position with the primary imaging modality for each group, need to perform tube position adjustment maneuvers, need to use fiberoptic bronchoscope during the case, quality of lung collapse, problems with ventilation and other.

The primary hypothesis is that the new Vivasight DL tube system will provide a comparable optical view to the fiberoptic scope view obtained via standard double lumen endotracheal tube in order to confirm optimal position.

Study Type

Interventional

Enrollment (Actual)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Galway, Ireland
        • Galway University Hospitals

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years to 85 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 16 - 85 yr old patients capable of informed consent
  • ASA (American Society of Anesthesiologists physical status) 1-3
  • non-emergency surgery of expected duration < 6 hours
  • one-lung ventilation required

Exclusion Criteria:

  • BMI > 35
  • expected difficult airway
  • Mallampati score >2
  • increased risk of aspiration
  • upper airway or upper GI problems
  • live pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Vivasight DL
placement and intraoperative use of Vivasight DL double lumen endobronchial tube
Active Comparator: standard DLT
placement and intraoperative use of a standard double lumen endotracheal tube.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adequacy of optical view obtained to confirm optimal tube position.
Time Frame: within 60 minutes of commencement of general anesthesia
The hypothesis is that the new Vivasight DL tube system will provide a comparable optical view to the fiberoptic scope view obtained via standard double lumen endotracheal tube in order to confirm optimal position.
within 60 minutes of commencement of general anesthesia

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to confirmation of tube position
Time Frame: within 60 minutes of commencement of general anesthesia
within 60 minutes of commencement of general anesthesia
Operator rated Device Difficulty Score
Time Frame: within 60 minutes of commencement of general anesthesia
The investigators will use 10cm visual analogue scale (VAS) to rate the overall ease of device use till successful placement achieved and position confirmed optically.
within 60 minutes of commencement of general anesthesia
Time from initial laryngoscopy to passing tube through vocal cords
Time Frame: Within 60 minutes of commencement of general anesthesia
Within 60 minutes of commencement of general anesthesia
rate of malposition
Time Frame: within 15 hours of commencement of general anesthesia
the investigators will record the number/type of tube position adjustment maneuvers
within 15 hours of commencement of general anesthesia
need to pass a fiberoptic bronchoscope during case
Time Frame: within 15 hours of commencement of general anesthesia
within 15 hours of commencement of general anesthesia
presence of blood at the carina immediately post intubation
Time Frame: within 60 minutes of commencement of general anesthesia
within 60 minutes of commencement of general anesthesia

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Brian Harte, FFARCSI, Galway University Hospitals

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2012

Primary Completion (Actual)

January 1, 2013

Study Completion (Actual)

January 1, 2013

Study Registration Dates

First Submitted

December 22, 2012

First Submitted That Met QC Criteria

December 22, 2012

First Posted (Estimate)

December 31, 2012

Study Record Updates

Last Update Posted (Estimate)

March 19, 2013

Last Update Submitted That Met QC Criteria

March 15, 2013

Last Verified

March 1, 2013

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Performance and Safety of an Airway Management Device

Clinical Trials on double lumen endotracheal tube placement and use

3
Subscribe